Yiduo Zhou

ORCID: 0009-0007-9294-7128
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Phagocytosis and Immune Regulation
  • Pancreatic and Hepatic Oncology Research
  • Cancer Immunotherapy and Biomarkers
  • Chronic Lymphocytic Leukemia Research
  • Cancer Mechanisms and Therapy
  • Adenosine and Purinergic Signaling
  • Thermal Regulation in Medicine
  • Pharmacological Effects of Natural Compounds
  • Medical Research and Treatments
  • Traditional Chinese Medicine Studies
  • Urinary Bladder and Prostate Research
  • Advanced Glycation End Products research
  • Urinary Tract Infections Management
  • Acupuncture Treatment Research Studies
  • Bladder and Urothelial Cancer Treatments
  • Mathematical Biology Tumor Growth
  • Autophagy in Disease and Therapy
  • Cell Adhesion Molecules Research
  • Pancreatic function and diabetes
  • Microbial Fuel Cells and Bioremediation
  • Urological Disorders and Treatments
  • Inflammatory Bowel Disease
  • Advanced Queuing Theory Analysis
  • Pelvic floor disorders treatments
  • Anorectal Disease Treatments and Outcomes

State Key Laboratory of Food Science and Technology
2025

State Key Laboratory of Food Nutrition and Safety
2025

Tianjin University of Science and Technology
2025

Women's Hospital, School of Medicine, Zhejiang University
2023

Second Affiliated Hospital of Nanjing Medical University
2020-2022

Hebei Agricultural University
2022

Institute of Food Science and Technology
2022

Jiangxi University of Traditional Chinese Medicine
2021

Health Commission of Anhui Province
2021

MRC Laboratory of Molecular Biology
2008

SUPERFAMILY provides structural, functional and evolutionary information for proteins from all completely sequenced genomes, large sequence collections such as UniProt. Protein domain assignments over 900 genomes are included in the database, which can be accessed at http://supfam.org/. Hidden Markov models based on Structural Classification of Proteins (SCOP) definitions superfamily level used to provide structural annotation. We recently produced a new model library SCOP 1.73. Family also...

10.1093/nar/gkn762 article EN cc-by-nc Nucleic Acids Research 2008-11-26

Bacterial cellulose (BC) is a nanocellulose produced by bacteria, formed glucose units linked through β-1,4 glycosidic bonds. It features three-dimensional network structure, superior water retention capacity, high porosity, and outstanding biocompatibility, among other notable characteristics. Komagataeibacter xylinus was the predominant strain used for BC production. The CRISPR/Cas9 (clustered regularly interspaced short palindromic repeats/CRISPR associate-protein 9)-mediated gene editing...

10.1021/acssynbio.4c00785 article EN ACS Synthetic Biology 2025-03-18

Pancreatic ductal adenocarcinoma (PDAC) remains a highly lethal malignancy because of its aggressive nature and the paucity effective treatment options. Almost all registered drugs have proven ineffective in addressing needs patients with PDAC. This is result poor understanding unique tumor-immune microenvironment (TME) To identify druggable regulators immunosuppressive TME, we performed kinome- membranome-focused CRISPR screening using orthotopic PDAC models. Our data showed that...

10.1158/2159-8290.cd-23-0584 article EN Cancer Discovery 2023-10-12

Interstitial cystitis (IC) is a clinical syndrome characterized by frequency, urgency, and bladder pain or pelvic pain; however, the underlying pathophysiological mechanisms diagnostic markers are unknown. In this study, microbiome metabolome analysis were used to explain urine signatures of IC patients. Urine samples from 20 patients 22 control groups analyzed using 16S rRNA sequence liquid chromatography coupled with mass spectrometry. Four opportunistic pathogen genera, including...

10.3389/fcimb.2021.711746 article EN cc-by Frontiers in Cellular and Infection Microbiology 2021-08-30

Diabetic cystopathy (DCP) is a chronic complication of diabetes mainly within the submucosal and muscular layers bladder due to hyperglycemia-induced ischemia. As no effective therapies are currently available, administration optimized mesenchymal stem cells (MSCs) provides potential treatment DCP. Thus far, new strategy, such as genetic modification MSCs, has been developed shown promising outcomes various disorders. This study was conducted using integrin-linked kinase (ILK) gene-modified...

10.1186/s13287-020-01795-4 article EN cc-by Stem Cell Research & Therapy 2020-07-10

The hyphenation of ion mobility spectrometry with high-resolution mass has been widely used in the characterization various metabolites. Nevertheless, such a powerful tool remains largely unexplored natural products research, possibly mainly due to lack available compounds. To evaluate ability collision cross-sections (CCSs) characterizing compounds, especially isomeric products, here we measured and compared traveling-wave IMS-derived nitrogen CCS values for 75 marine-derived aphidicolanes....

10.3390/md20090541 article EN cc-by Marine Drugs 2022-08-23

Ulcerative colitis (UC) is a chronic nonspecific intestinal inflammatory disease with unclear etiology occurring in the colonic mucosa. Its clinical manifestations are characterized by recurrent abdominal pain, diarrhea, mucous pus, and blood stool. The severity of varies, itis high recurrence rate. Because its long course disease, easy to relapse, protracted difficult recover, seriously affect quality life, increase economic burden patients society, even risk developing cancer, it has...

10.1097/md.0000000000024078 article EN cc-by-nc Medicine 2021-01-29

<div>Abstract<p>Pancreatic ductal adenocarcinoma (PDAC) remains a highly lethal malignancy because of its aggressive nature and the paucity effective treatment options. Almost all registered drugs have proven ineffective in addressing needs patients with PDAC. This is result poor understanding unique tumor–immune microenvironment (TME) To identify druggable regulators immunosuppressive TME, we performed kinome- membranome-focused CRISPR screening using orthotopic PDAC models. Our...

10.1158/2159-8290.c.7065337.v1 preprint EN 2024-02-08

<p>Supplementary Figure S1. In vivo CRISPR screens to identify critical drivers of immune evasion; Supplementary S2. Effects Ripk2 depletion on tumor growth; S3. RIPK2 is overexpressed in human and mouse PDAC tissues; S4. Ablation disrupts the desmoplastic TME; S5. modulates profile impairs anti-tumor T cell response; S6. restricts activation effector states CD8+ cells by impairing antigen presentation; S7. promotes MHC-I trafficking lysosomes via NBR1; S8. ubiquitination NBR1-mediated...

10.1158/2159-8290.25191545.v1 preprint EN cc-by 2024-02-08

<div>Abstract<p>Pancreatic ductal adenocarcinoma (PDAC) remains a highly lethal malignancy because of its aggressive nature and the paucity effective treatment options. Almost all registered drugs have proven ineffective in addressing needs patients with PDAC. This is result poor understanding unique tumor–immune microenvironment (TME) To identify druggable regulators immunosuppressive TME, we performed kinome- membranome-focused CRISPR screening using orthotopic PDAC models. Our...

10.1158/2159-8290.c.7065337.v2 preprint EN 2024-02-08

<div>Abstract<p>Pancreatic ductal adenocarcinoma (PDAC) remains a highly lethal malignancy because of its aggressive nature and the paucity effective treatment options. Almost all registered drugs have proven ineffective in addressing needs patients with PDAC. This is result poor understanding unique tumor–immune microenvironment (TME) To identify druggable regulators immunosuppressive TME, we performed kinome- membranome-focused CRISPR screening using orthotopic PDAC models. Our...

10.1158/2159-8290.c.7065337 preprint EN 2024-02-08

<p>Supplementary Figure S1. In vivo CRISPR screens to identify critical drivers of immune evasion; Supplementary S2. Effects Ripk2 depletion on tumor growth; S3. RIPK2 is overexpressed in human and mouse PDAC tissues; S4. Ablation disrupts the desmoplastic TME; S5. modulates profile impairs anti-tumor T cell response; S6. restricts activation effector states CD8+ cells by impairing antigen presentation; S7. promotes MHC-I trafficking lysosomes via NBR1; S8. ubiquitination NBR1-mediated...

10.1158/2159-8290.25191545 preprint EN cc-by 2024-02-08

<p>Supplementary Figure S1. In vivo CRISPR screens to identify critical drivers of immune evasion; Supplementary S2. Effects Ripk2 depletion on tumor growth; S3. RIPK2 is overexpressed in human and mouse PDAC tissues; S4. Ablation disrupts the desmoplastic TME; S5. modulates profile impairs anti-tumor T cell response; S6. restricts activation effector states CD8+ cells by impairing antigen presentation; S7. promotes MHC-I trafficking lysosomes via NBR1; S8. ubiquitination NBR1-mediated...

10.1158/2159-8290.25183972 preprint EN cc-by 2024-02-08
Coming Soon ...